Global Ankylosing Spondylitis Market 2015-2019

Global Ankylosing Spondylitis Market 2015-2019

  • January 2015 •
  • 102 pages •
  • Report ID: 2608402 •
  • Format: PDF
About Ankylosing Spondylitis
Ankylosing spondylitis is a subtype of spondylarthropathy. The primary symptoms of the disease are inflammatory spinal pain with subsequent limitation of spine mobility and chest expansion. Ankylosing spondylitis can be diagnosed using clinical signs, radiological signs (sacroiliitis) and the presence of HLA-B27 antigen. According to the NIH and NIAMS, ankylosing spondylitis is a type of arthritis, which affects the joints in the vertebral column severely. It is a progressive inflammatory disease that typically becomes evident during early to mid-adulthood, as per NORD. It can also lead to the loss of spinal mobility for the affected individuals. The cause of the disease is not known, however, the HLA-B27 gene plays a major role. Ankylosing spondylitis is hereditary in nature.
TechNavio's analysts forecast the Global Ankylosing Spondylitis market to grow at a CAGR of 5.05 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Ankylosing Spondylitis market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of ankylosing spondylitis. The market is segmented based on the mechanism of action of the drugs used to treat ankylosing spondylitis as illustrated below:
• TNF Inhibitors
• COX Inhibitors
• Others
On the type of molecule used for the treatment of ankylosing spondylitis, as illustrated below:
• Biologics
• Small Molecules
On the basis of route of administration adopted for the treatment of ankylosing spondylitis, the Global Ankylosing Spondylitis market is segmented as follows:
• Oral
• Parenteral
In addition, the market is also bifurcated on the basis of dosage forms of the drugs used in the treatment of the disease:
• Solid
• Liquid
The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market and also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market. Also, the late-stage pipeline molecules developed for the treatment of Ankylosing Spondylitis have been discussed.
TechNavio's report, Global Ankylosing Spondylitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region and the EMEA; it also covers the Global Ankylosing Spondylitis market landscape and its growth prospects in the coming years. The report also includes a discussion on the key vendors operating in this market.

Key Regions
• Americas

Key Vendors
• Abbvie
• Amgen
• Janssen Pharmaceuticals
• Merck & Co.
• Pfizer
Other Prominent Vendors

• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celgene
• Celltrion
• Eisai
• F. Hoffmann-La Roche
• Merck Sharp & Dohme
• Novartis
• Otsuka Pharmaceutical
• Regeneron Pharmaceuticals
• Sanofi
• Shanghai Pharmaceuticals

Market Driver
• Presence of Unmet Need
• For a full, detailed list, view our report

Market Challenge
• Threat from Patent Expiry
• For a full, detailed list, view our report

Market Trend
• Market Dominance by Biologics
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

We are very sorry, but an error occurred.
Please contact if the problem remains.